Guidelines for CBD When Patients Are Using Medications Metabolized by the P450 System
Answers from SCC Members to an inquiry on the safety of using CBD when patients are taking medications metabolized by the P450 system.
The endocannabinoidome as a substrate for noneuphoric phytocannabinoid action and gut microbiome dysfunction in neuropsychiatric disorders
Authors: Vincenzo Di Marzo, PhD Published in DIALOGUES IN CLINICAL NEUROSCIENCE 2020 Abstract The endocannabinoid (eCB) system encompasses the eCBs anandamide and 2-arachidonoylglycerol, their anabolic/catabolic enzymes, and the cannabinoid CB1…
Neurobiology of cannabinoid receptor signaling
Authors: Beat Lutz, PhD Published in DIALOGUES IN CLINICAL NEUROSCIENCE 2020 Abstract The endocannabinoid system (ECS) is a highly versatile signaling system within the nervous system. Despite its widespread localization,…
Cannabidiol in conjunction with clobazam: analysis of four randomized‐controlled trials
Authors: Boudewijn Gunning, Maria Mazurkiewicz‐Beldzinska, Richard F.M. Chin, Hari Bhathal Charlotte Nortvedt, Eduardo Dunayevich, Daniel Checketts Published in Acta Neurologica Scandinavica September 2020 Abstract Objectives To assess the efficacy and…
A pediatric patient with autism spectrum disorder and epilepsy using cannabinoid extracts as complementary therapy: a case report
Authors: Juliana Andrea Ponton, Kim Smyth, Elias Soumbasis, Sergio Andres Llanos, Mark Lewis, Wilhelm August Meerholz & Robert Lawrence Tanguay Published in Journal of Medical Case Reports September 2020 Abstract…
Understanding Cannabis-Based Therapeutics in Sports Medicine
SCC Member Gretchen E. Maurer, DO, MS and colleagues examine the current research potential for cannabis in sports medicine.
Acute effects of naturalistic THC vs. CBD use on recognition memory: a preliminary study
Authors: Tim Curran , Hélène Devillez , Sophie L. York Williams and L. Cinnamon Bidwell Published in Journal of Cannabis Research 2020 Abstract The ratio of Δ9-tetrahydrocannabinol (THC) to cannabidiol…
Most Patients Believe Their Doctors Aren’t a “Good Source” of Information on Cannabis
Survey data reported that less than 20% of patients believe that their primary care providers are knowledgeable about cannabis-specific medical issues.
Perceptions and recommendation behaviors of dermatologists for medical cannabis: A pilot survey
Authors: Samuel Yeroushalmi, Kamaria Nelsona, Andrew Sparks, Adam Friedman Published in Complementary Therapies in Medicine September 2020 Abstract Objectives Evidence suggests that cannabinoids may provide therapeutic benefit to patients with…
Medical marijuana certification for patients with sickle cell disease: a report of a single center experience
Authors: Susanna A. Curtis, Dana Lew, Jonathan Spodick, Jeanne E. Hendrickson, Caterina P. Minniti, John D. Roberts Published in Blood Advances August 2020 Abstract More than one-third of adults with…
Cannabis use is associated with a lower risk of diabetes in chronic hepatitis C-infected patients (ANRS CO22 Hepather cohort)
Authors: Tangui Barré, Marie Libérée Nishimwe, Camelia Protopopescu, Fabienne Marcellin, Fabrice Carrat, Céline Dorival, Elisabeth Delarocque‐Astagneau, Dominique Larrey, Marc Bourlière, Ventzislava Petrov‐Sanchez, Mélanie Simony, Stanislas Pol, Hélène Fontaine, Patrizia Carrieri…
A Survey Exploring the Relationship Between Cannabis Use Characteristics and Sexual Function in Men
Authors: Hriday P. Bhambhvani BS, Alex M.Kasman MD, Genester Wilson-King MD, Michael L. Eisenberg MD Published in Sexual Medicine September 2020 Abstract Introduction Cannabis is the most commonly used drug…